MCL1 and neoplasm: miR-29 may elicit its tumor suppressive potential by repressing targets such as AKT3, DNMT3A/B, or MCL1 [7,8,9,10]; however, miR-29 hairpin inhibitors failed to increase the expression of these validated targets in A375 melanoma cells (Figure 3A).